{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:54:28Z","timestamp":1779216868220,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010747","name":"Consejo Nacional de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["134-2017-PROCIENCIA"],"award-info":[{"award-number":["134-2017-PROCIENCIA"]}],"id":[{"id":"10.13039\/501100010747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010747","name":"Consejo Nacional de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["134-2017-PROCIENCIA"],"award-info":[{"award-number":["134-2017-PROCIENCIA"]}],"id":[{"id":"10.13039\/501100010747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010747","name":"Consejo Nacional de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["134-2017-PROCIENCIA"],"award-info":[{"award-number":["134-2017-PROCIENCIA"]}],"id":[{"id":"10.13039\/501100010747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010747","name":"Consejo Nacional de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["134-2017-PROCIENCIA"],"award-info":[{"award-number":["134-2017-PROCIENCIA"]}],"id":[{"id":"10.13039\/501100010747","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universidad Cientifica del Sur"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Gastric cancer is the fourth most common cancer globally and the leading cause of cancer-related deaths in Peru. Current synthetic treatments often fail to distinguish cancerous cells from healthy cells, resulting in severe side effects and drug resistance. This study aimed to evaluate the effects of the chloroform fraction of <jats:italic>Dracontium spruceanum<\/jats:italic> bulb (DSBCl) on cancer stem cells (CSCs) from AGS and KATO III gastric cancer cell lines, which represent primary and metastatic cancers. The methanolic extract was prepared and characterized via thin-layer chromatography to isolate the chloroform fraction. CSCs were identified via the CD44 marker and isolated via magnetic assisted cell sorting. The cytotoxic effect of DSBCl was evaluated to determine the IC<jats:sub>50<\/jats:sub>, revealing its ability to modulate CSC markers and genes associated with tumorigenesis, chemoresistance, and metastasis. In AGS CSCs, DSBCl reduced CD24 expression and downregulated the expression of genes, including <jats:italic>ID1, BCL2L2, ABCC2, NANOG,<\/jats:italic> and <jats:italic>OCT4<\/jats:italic>, while it upregulated <jats:italic>KLF17, BAX,<\/jats:italic> and <jats:italic>KLF4<\/jats:italic>. In KATO III CSCs, DSBCl increased <jats:italic>ID1<\/jats:italic> and <jats:italic>MYC<\/jats:italic> but decreased <jats:italic>BCL2L1<\/jats:italic> and <jats:italic>BAX<\/jats:italic>. These findings suggest that DSBCl modulates critical markers and genes in gastric CSCs, highlighting its potential for gastric cancer treatment.<\/jats:p>","DOI":"10.1038\/s41598-025-15172-9","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T20:23:05Z","timestamp":1756326185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The chloroform fraction of Dracontium spruceanum modulates gene expression in gastric cancer stem cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Salyoc","family":"Tapia-Rojas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Amiel-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Fukusaki-Yoshizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obert","family":"Mar\u00edn-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Mayanga-Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"15172_CR1","first-page":"229","volume":"74","author":"J Ferlay","year":"2024","unstructured":"Ferlay, J. et al. Global cancer observatory: Cancer today. Int. J. Cancer 74, 229\u2013263 (2024).","journal-title":"Int. J. Cancer"},{"key":"15172_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.mcna.2017.06.003","volume":"101","author":"N Gegechkori","year":"2017","unstructured":"Gegechkori, N., Haines, L. & Lin, J. J. Long-term and latent side effects of specific cancer types. Med. Clin. N. Am. 101, 1053\u20131073 (2017).","journal-title":"Med. Clin. N. Am."},{"key":"15172_CR3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i34.3834","author":"K Van der Jeught","year":"2018","unstructured":"Van der Jeught, K., Xu, H. C., Li, Y. J., Lu, X. B. & Ji, G. Drug resistance and new therapies in colorectal cancer. World J. Gastroenterol. https:\/\/doi.org\/10.3748\/wjg.v24.i34.3834 (2018).","journal-title":"World J. Gastroenterol."},{"key":"15172_CR4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3349\/ymj.2018.59.10.1150","volume":"59","author":"Y Fu","year":"2018","unstructured":"Fu, Y. et al. Gastric cancer stem cells: Mechanisms and therapeutic approaches. Yonsei Med. J. 59, 1150\u20131158 (2018).","journal-title":"Yonsei Med. J."},{"key":"15172_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124\u20131134 (2017).","journal-title":"Nat. Med."},{"key":"15172_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/stem.30","volume":"27","author":"S Takaishi","year":"2009","unstructured":"Takaishi, S. et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27, 1006\u20131020 (2009).","journal-title":"Stem Cells"},{"key":"15172_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.515","volume":"5","author":"J Mao","year":"2014","unstructured":"Mao, J. et al. Roles of Wnt\/\u03b2-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 5, e1039 (2014).","journal-title":"Cell Death Dis."},{"key":"15172_CR8","doi-asserted-by":"publisher","first-page":"9815","DOI":"10.18632\/oncotarget.6890","volume":"7","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. Oncotarget 7, 9815 (2016).","journal-title":"Oncotarget"},{"key":"15172_CR9","first-page":"174","volume":"15","author":"R Lu","year":"2012","unstructured":"Lu, R. et al. Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties. Zhonghua Wei Chang Wai Ke Za Zhi 15, 174\u2013179 (2012).","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"15172_CR10","first-page":"279","volume":"3","author":"A Nosrati","year":"2014","unstructured":"Nosrati, A., Naghshvar, F. & Khanari, S. Cancer stem cell markers CD44, CD133 in primary gastric adenocarcinoma. Int. J. Mol. Cell. Med. 3, 279 (2014).","journal-title":"Int. J. Mol. Cell. Med."},{"key":"15172_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5230\/jgc.2010.10.3.99","volume":"10","author":"HJ Lee","year":"2010","unstructured":"Lee, H. J., Choi, Y. S., Kim, S. J. & Moon, H. J. CD44 and CD133 as cancer stem cell markers for gastric cancer. J. Gastr. Cancer 10, 99\u2013105 (2010).","journal-title":"J. Gastr. Cancer"},{"key":"15172_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/1871520615666150520143827","volume":"16","author":"NJ Nwodo","year":"2015","unstructured":"Nwodo, N. J., Ibezim, A., Simoben, V. C. & Ntie-Kang, F. Exploring cancer therapeutics with natural products from African medicinal plants, part II: Alkaloids, terpenoids and flavonoids. Anticancer Agents Med. Chem. 16, 108\u2013127 (2015).","journal-title":"Anticancer Agents Med. Chem."},{"key":"15172_CR13","first-page":"97","volume":"31","author":"E Vega","year":"2006","unstructured":"Vega, E., Velasco, R. & Jim\u00e9nez, M. Las plantas como fuente de compuestos antineopl\u00e1sicos. Bioqu\u00edmica 31, 97\u2013111 (2006).","journal-title":"Bioqu\u00edmica"},{"key":"15172_CR14","first-page":"1588","volume":"7","author":"WF Taylor","year":"2017","unstructured":"Taylor, W. F. & Jabbarzadeh, E. The use of natural products to target cancer stem cells. Am. J. Cancer Res. 7, 1588 (2017).","journal-title":"Am. J. Cancer Res."},{"key":"15172_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-8741(00)00341-X","author":"JG Graham","year":"2000","unstructured":"Graham, J. G., Quinn, M. L., Fabricant, D. S. & Farnsworth, N. R. Plants used against cancer\u2014An extension of the work of Jonathan Hartwell. J. Ethnopharmacol. https:\/\/doi.org\/10.1016\/S0378-8741(00)00341-X (2000).","journal-title":"J. Ethnopharmacol."},{"key":"15172_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5812\/jjnpp-145843","volume":"19","author":"A Rodriguez-Huamani","year":"2024","unstructured":"Rodriguez-Huamani, A. et al. Cytotoxicity of fractions of Dracontium spruceanum chloroform extract in MDA-MB-231 and MCF-7 breast cancer cell lines. Jundishapur J. Nat. Pharm. Prod. 19, 3 (2024).","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"key":"15172_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jpbs.JPBS_175_19","volume":"12","author":"AR Abubakar","year":"2020","unstructured":"Abubakar, A. R. & Haque, M. Preparation of medicinal plants: Basic extraction and fractionation procedures for experimental purposes. J. Pharm. Bioallied Sci. 12, 1\u201310 (2020).","journal-title":"J. Pharm. Bioallied Sci."},{"key":"15172_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3892\/ijmm.2016.2625","volume":"38","author":"X Shen","year":"2016","unstructured":"Shen, X. et al. Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K\/Akt signaling. Int. J. Mol. Med. 38, 619\u2013626 (2016).","journal-title":"Int. J. Mol. Med."},{"key":"15172_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1563229","volume":"16","author":"X Xie","year":"2025","unstructured":"Xie, X. & Wei, Y. A review on anti-cancer properties of quercetin in gastric cancer. Front. Pharmacol. 16, 1563229 (2025).","journal-title":"Front. Pharmacol."},{"key":"15172_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101021","volume":"14","author":"Z Chu","year":"2024","unstructured":"Chu, Z. et al. Terpene extract from the stem of Celastrus orbiculatus inhibits actin cytoskeleton remodelling in gastric cancer cells by regulating the protein interaction between PTBP1 and ACTN4. J. Pharm. Anal. 14, 101021 (2024).","journal-title":"J. Pharm. Anal."},{"key":"15172_CR21","volume-title":"Evaluaci\u00f3n de la actividad antiproliferativa, antioxidante y antiinflamatoria in vitro del extracto metan\u00f3lico de hojas de Piper aduncum, Buddleja incana y Dracontium spruceanum","author":"VE Miranda Garcia","year":"2019","unstructured":"Miranda Garcia, V. E. Evaluaci\u00f3n de la actividad antiproliferativa, antioxidante y antiinflamatoria in vitro del extracto metan\u00f3lico de hojas de Piper aduncum, Buddleja incana y Dracontium spruceanum (Universidad Nacional Mayor de San Marcos, 2019)."},{"key":"15172_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-81196-2","volume":"14","author":"Y Song","year":"2024","unstructured":"Song, Y. et al. Wogonin suppresses proliferation, invasion and migration in gastric cancer cells via targeting the JAK-STAT3 pathway. Sci. Rep. 14, 1\u201315 (2024).","journal-title":"Sci. Rep."},{"key":"15172_CR23","first-page":"634","volume":"34","author":"C Sun","year":"2019","unstructured":"Sun, C., Zhang, S., Liu, C. & Liu, X. Curcumin promoted miR-34a expression and suppressed proliferation of gastric cancer cells. Cancer Biother. Radiopharm. 34, 634\u2013641 (2019).","journal-title":"Cancer Biother. Radiopharm."},{"key":"15172_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1498213","volume":"14","author":"S Li","year":"2024","unstructured":"Li, S. et al. Triptolide suppresses IL-1\u03b2-induced expression of interleukin-8 by inhibiting ROS-mediated ERK, AP-1, and NF-\u03baB molecules in human gastric cancer AGS cells. Front. Oncol. 14, 1498213 (2024).","journal-title":"Front. Oncol."},{"key":"15172_CR25","first-page":"367","volume":"79","author":"AN Sandoval","year":"2020","unstructured":"Sandoval, A. N. et al. Toxicity in artemia salina by hydroalcoholic extracts of monocotyledonous and dicotyledonous varieties of medicinal plants from the Peruvian Amazon. Chem. Eng. Trans. 79, 367\u2013372 (2020).","journal-title":"Chem. Eng. Trans."},{"key":"15172_CR26","first-page":"117","volume":"77","author":"IE Collantes","year":"2011","unstructured":"Collantes, I. E., Gon\u00e7alves, E. G. & Yoshida, M. Constituyentes quimicos del t\u00fabero de Dracontium spruceanum (Schott) G.Zhu ex Dracontium loretense Krause (Araceae). Rev. Soc. Qu\u00edm. Per\u00fa 77, 117\u2013126 (2011).","journal-title":"Rev. Soc. Qu\u00edm. Per\u00fa"},{"key":"15172_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1590\/1678-457x.23217","volume":"38","author":"C Kapcum","year":"2018","unstructured":"Kapcum, C. & Uriyapongson, J. Effects of storage conditions on phytochemical and stability of purple corn cob extract powder. Food Sci. Technol. Brazil 38, 301\u2013305 (2018).","journal-title":"Food Sci. Technol. Brazil"},{"key":"15172_CR28","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1021\/jf062914w","volume":"55","author":"A Srivastava","year":"2007","unstructured":"Srivastava, A., Akoh, C. C., Yi, W., Fischer, J. & Krewer, G. Effect of storage conditions on the biological activity of phenolic compounds of blueberry extract packed in glass bottles. J. Agric. Food Chem. 55, 2705\u20132713 (2007).","journal-title":"J. Agric. Food Chem."},{"key":"15172_CR29","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00432-011-1038-5","volume":"137","author":"C Zhang","year":"2011","unstructured":"Zhang, C., Li, C., He, F., Cai, Y. & Yang, H. Identification of CD44+CD24+ gastric cancer stem cells. J. Cancer Res. Clin. Oncol. 137, 1679\u20131686 (2011).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"15172_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40169-018-0198-1","volume":"7","author":"PM Glumac","year":"2018","unstructured":"Glumac, P. M. & LeBeau, A. M. The role of CD133 in cancer: A concise review. Clin. Transl. Med. 7, 18 (2018).","journal-title":"Clin. Transl. Med."},{"key":"15172_CR31","first-page":"61","volume":"48","author":"M Sekiguchi","year":"1978","unstructured":"Sekiguchi, M., Sakakibara, K. & Fujii, G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn. J. Exp. Med. 48, 61\u201368 (1978).","journal-title":"Jpn. J. Exp. Med."},{"key":"15172_CR32","first-page":"5023","volume":"17","author":"G Kim","year":"2019","unstructured":"Kim, G. et al. The effects of BRCA1 expression on the chemosensitivity of gastric cancer cells to platinum agents. Oncol. Lett. 17, 5023 (2019).","journal-title":"Oncol. Lett."},{"key":"15172_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-021-03444-6","volume":"21","author":"TDT Tam","year":"2021","unstructured":"Tam, T. D. T. et al. Ethyl acetate extract of Elephantopus mollis Kunth induces apoptosis in human gastric cancer cells. BMC Complement. Med. Ther. 21, 1\u201312 (2021).","journal-title":"BMC Complement. Med. Ther."},{"key":"15172_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.17843\/rpmesp.2020.373.5157","volume":"37","author":"A Mayanga-Herrera","year":"2020","unstructured":"Mayanga-Herrera, A., Tapia-Rojas, S., Fukusaki-Yoshizawa, A., Marcelo-Rodr\u00edguez, \u00c1. & Amiel-P\u00e9rez, J. Actividad citot\u00f3xica de la fracci\u00f3n clorof\u00f3rmica de Piper aduncum y su efecto en el ciclo celular en l\u00edneas celulares de c\u00e1ncer g\u00e1strico. Rev. Peru Med. Exp. Salud Publica 37, 471\u2013477 (2020).","journal-title":"Rev. Peru Med. Exp. Salud Publica"},{"key":"15172_CR35","first-page":"6768","volume":"17","author":"XX He","year":"2018","unstructured":"He, X. X., Huang, C. K. & Xie, B. S. Autophagy inhibition enhanced 5-FU-induced cell death in human gastric carcinoma BGC-823 cells. Mol. Med. Rep. 17, 6768\u20136776 (2018).","journal-title":"Mol. Med. Rep."},{"key":"15172_CR36","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.1158\/1078-0432.CCR-05-0606","volume":"11","author":"W Weichert","year":"2005","unstructured":"Weichert, W. et al. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin. Cancer Res. 11, 6574\u20136581 (2005).","journal-title":"Clin. Cancer Res."},{"key":"15172_CR37","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3748\/wjg.v22.i7.2373","volume":"22","author":"ZF Jia","year":"2016","unstructured":"Jia, Z. F. et al. CD24 genetic variants contribute to overall survival in patients with gastric cancer. World J. Gastroenterol. 22, 2373 (2016).","journal-title":"World J. Gastroenterol."},{"key":"15172_CR38","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1182\/blood.V89.9.3385","volume":"89","author":"S Aigner","year":"1997","unstructured":"Aigner, S. et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89, 3385\u20133395 (1997).","journal-title":"Blood"},{"key":"15172_CR39","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/cas.12522","volume":"105","author":"N Fujikuni","year":"2014","unstructured":"Fujikuni, N. et al. Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion. Cancer Sci. 105, 1411\u20131420 (2014).","journal-title":"Cancer Sci."},{"key":"15172_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1349-7006.2007.00643.x","volume":"99","author":"L Liu","year":"2008","unstructured":"Liu, L. et al. Hypoxia-inducible factor-1\u03b1 contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci. 99, 121\u2013128 (2008).","journal-title":"Cancer Sci."},{"key":"15172_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/sj.cgt.7701082","volume":"14","author":"Y Folmer","year":"2007","unstructured":"Folmer, Y., Schneider, M., Blum, H. E. & Hafkemeyer, P. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs. Cancer Gene Ther. 14, 875\u2013884 (2007).","journal-title":"Cancer Gene Ther."},{"key":"15172_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.672287","volume":"11","author":"F Loscocco","year":"2021","unstructured":"Loscocco, F. et al. Clinical relevance of ABCB1, ABCG2, and ABCC2 gene polymorphisms in chronic myeloid leukemia patients treated with nilotinib. Front. Oncol. 11, 672287 (2021).","journal-title":"Front. Oncol."},{"key":"15172_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1407-6","author":"CFA Warren","year":"2019","unstructured":"Warren, C. F. A., Wong-Brown, M. W. & Bowden, N. A. BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-019-1407-6 (2019).","journal-title":"Cell Death Dis."},{"key":"15172_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.18","volume":"1","author":"WJ Placzek","year":"2010","unstructured":"Placzek, W. J. et al. A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis. 1, e40 (2010).","journal-title":"Cell Death Dis."},{"key":"15172_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079626","volume":"8","author":"JH Kim","year":"2013","unstructured":"Kim, J. H. & Bae, J. MCL-1ES induces MCL-1L-dependent BAX- And BAK-independent mitochondrial apoptosis. PLoS ONE 8, e79626 (2013).","journal-title":"PLoS ONE"},{"key":"15172_CR46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/138945010791170842","volume":"11","author":"H Yang","year":"2010","unstructured":"Yang, H. & Ping Dou, Q. Targeting apoptosis pathway with natural terpenoids: Implications for treatment of breast and prostate cancer. Curr. Drug Targets 11, 733\u2013744 (2010).","journal-title":"Curr. Drug Targets"},{"key":"15172_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/cancers11010028","volume":"11","author":"M Abotaleb","year":"2018","unstructured":"Abotaleb, M. et al. Flavonoids in cancer and apoptosis. Cancers 11, 28 (2018).","journal-title":"Cancers"},{"key":"15172_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00487","author":"Q Ye","year":"2019","unstructured":"Ye, Q. et al. Reversal of multidrug resistance in cancer by multi-functional flavonoids. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00487 (2019).","journal-title":"Front. Oncol."},{"key":"15172_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3892\/ol.2015.3884","volume":"11","author":"X Zhao","year":"2016","unstructured":"Zhao, X., Wang, F. & Hou, M. Expression of stem cell markers nanog and PSCA in gastric cancer and its significance. Oncol. Lett. 11, 442\u2013448 (2016).","journal-title":"Oncol. Lett."},{"key":"15172_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12029-018-00200-x","volume":"51","author":"G Basati","year":"2020","unstructured":"Basati, G., Mohammadpour, H. & Emami Razavi, A. Association of high expression levels of SOX2, NANOG, and OCT4 in gastric cancer tumor tissues with progression and poor prognosis. J. Gastrointest. Cancer 51, 41\u201347 (2020).","journal-title":"J. Gastrointest. Cancer"},{"key":"15172_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi243","author":"D Wei","year":"2006","unstructured":"Wei, D., Kanai, M., Huang, S. & Xie, K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis https:\/\/doi.org\/10.1093\/carcin\/bgi243 (2006).","journal-title":"Carcinogenesis"},{"key":"15172_CR52","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/ol.2016.5499","volume":"13","author":"I Hashimoto","year":"2017","unstructured":"Hashimoto, I. et al. Prognostic significance of KLF4 expression in gastric cancer. Oncol. Lett. 13, 819\u2013826 (2017).","journal-title":"Oncol. Lett."},{"key":"15172_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03000605211051581","volume":"49","author":"S Li","year":"2021","unstructured":"Li, S., Li, Y., Tan, B. & An, Z. Effect of KLF17 overexpression on epithelial\u2013mesenchymal transition of gastric cancer cells. J. Int. Med. Res. 49, 1\u201316 (2021).","journal-title":"J. Int. Med. Res."},{"key":"15172_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20587384211010925","volume":"35","author":"ZJ An","year":"2021","unstructured":"An, Z. J. et al. Up-regulation of KLF17 expression increases the sensitivity of gastric cancer to 5-fluorouracil. Int. J. Immunopathol. Pharmacol. 35, 1\u201312 (2021).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"15172_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-016-0161-y","author":"C Roschger","year":"2017","unstructured":"Roschger, C. & Cabrele, C. The Id-protein family in developmental and cancer-associated pathways Fritz Aberger. Cell Commun. Signal. https:\/\/doi.org\/10.1186\/s12964-016-0161-y (2017).","journal-title":"Cell Commun. Signal."},{"key":"15172_CR56","doi-asserted-by":"publisher","first-page":"995","DOI":"10.7150\/ijms.42805","volume":"17","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z., Bo, Z., Gong, W. & Guo, Y. Inhibitor of differentiation 1 (Id1) in cancer and cancer therapy. Int. J. Med. Sci. 17, 995 (2020).","journal-title":"Int. J. Med. Sci."},{"key":"15172_CR57","volume":"10","author":"B Chen","year":"2020","unstructured":"Chen, B. et al. PTBP3 induced inhibition of differentiation of gastric cancer cells through alternative splicing of Id1. Front. Oncol. 10, 525988 (2020).","journal-title":"Front. Oncol."},{"key":"15172_CR58","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3892\/mmr.2012.749","volume":"5","author":"G Yang","year":"2012","unstructured":"Yang, G. et al. Downregulation of Id1 by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway. Mol. Med. Rep. 5, 1075\u20131079 (2012).","journal-title":"Mol. Med. Rep."},{"key":"15172_CR59","doi-asserted-by":"publisher","DOI":"10.18800\/9788483909522","volume-title":"Investigaci\u00f3n Fitoqu\u00edmica: M\u00e9todos en el Estudio de Productos Naturales","author":"O Lock Sing de Ugaz","year":"1994","unstructured":"Lock Sing de Ugaz, O. Investigaci\u00f3n Fitoqu\u00edmica: M\u00e9todos en el Estudio de Productos Naturales (Pontificia Universidad Cat\u00f3lica del Per\u00fa Departamento de Ciencias, 1994)."},{"key":"15172_CR60","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15172-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15172-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15172-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:20:49Z","timestamp":1757485249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15172-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15172"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15172-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31645"}}